- MeSH
- Time Factors MeSH
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Mastectomy * methods statistics & numerical data MeSH
- Breast Neoplasms * surgery MeSH
- Patient Satisfaction MeSH
- Age Factors MeSH
- Plastic Surgery Procedures * methods statistics & numerical data MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Female MeSH
- MeSH
- Biopsy methods statistics & numerical data MeSH
- Adult MeSH
- Data Interpretation, Statistical MeSH
- Humans MeSH
- Mastectomy statistics & numerical data MeSH
- Breast Neoplasms diagnosis surgery therapy MeSH
- Mass Screening statistics & numerical data utilization MeSH
- Plastic Surgery Procedures trends utilization MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Female MeSH
Karcinom prsu je v České republice nejčastěji se vyskytujícím zhoubným nádorem u žen. Počet nově hlášených nádorů v posledních desetiletích postupně narůstá a jedná se i o nižší věkové kategorie. Díky mamografickému screeningu bývá karcinom objeven včas. Toto vyšetření má rozhodující vliv na snížení mortality.
The breast carcinoma is the most frequent malignancy in the women in the Czech Republic. The incidence of the breast carcinoma is still increasing. In the last years the number of the new report cases is higher also in young women. As the screening mamography is established in the Czech Republic, carcinoma is detected soon. This fact decreases mortality for the breast cancer.
- MeSH
- Adult MeSH
- Data Interpretation, Statistical MeSH
- Humans MeSH
- Lymph Node Excision statistics & numerical data utilization MeSH
- Mammography statistics & numerical data utilization MeSH
- Mastectomy statistics & numerical data utilization MeSH
- Breast Neoplasms diagnosis surgery therapy MeSH
- Retrospective Studies MeSH
- Age of Onset MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Female MeSH
Cíl: Nově zjištěné DCIS ve vyspělých zemích dosahují až 20 %. Neexistuje jednotné léčebné schéma. Cílem práce je zhodnotit výsledky vlastní léčby. Metoda; Od 1999 do 2003 bylo léčeno 11 pacientek DCIS a 2 pacientky s DCIS s mikroinvazí. Diagnóza byla stanovena 5x core-cut a 8x chirurgickou excizí. Výsledky: Velikost nádorů byla od 0,5 do 6,0 cm. Konzervativní výkony byly provedeny llx, prostá mastektomie Ix a jedenkrát mastektomie s rekonstrukcí. Sentinelová uzlina byla vyšetřena u všech a Ix doplněna disekcí axily. Počet sentinelových uzlin byl 29. Všechny uzliny byly negativní. Sedm pacientek mělo adjuvantní léčbu. Všechny pacientky jsou bez lokální recidívy v prsu a bez známek onemocnění. Průměrná doba sledování je 13,5 měsíců. Závěr: Konzervativní výkony dostatečně zajišťují léčbu časných forem DCIS prsu. Biopsie sentinelové uzliny je šetrná metoda, která přesně informuje o stavu axilárních uzlin a považujeme ji za vhodnou součást chirurgické terapie DCIS.
Aim; Rates of the newly-detected DCIS reach up to 20% in developed countries. There is no unified therapeutic scheme to deal with the disorder. The aim of this work is to assess the author's own therapeutic results. Methodology: From 1999 until 2003, 11 female patients suffering from the DCIS were treated and 2 DCIS female patients were treated using microinvasion. The diagnosis was established 5x by the core-cut and 8x by the surgical excision. Results: The size of the tumors varied from 0.5 cm to 6.0 cm. Conservative procedures were performed 11 times, a simple mastectomy once and a mastectomy with reconstruction once, as well. The sentinel lymphonodes were examined in all cases and once the examination was accompanied by the axilla dissection. The number of the sentinel lymphonodes was 29. All of the lymphonodes were negative. Seven female patients were given a complementary therapy. All female patients have had no local relapse in the breast and have had no signs of the disease process since. The average follow-up time is 13.5 months. Conclusion: The conservative procedures sufficiently provide treatment of early forms of the DCIS of the breast. The sentinel lymphonode biopsy is a patient- kind method, giving exact information on the status of the axillary lymphonodes and it is considered a suitable part of the DCIS therapy.
- MeSH
- Adult MeSH
- Drug Therapy methods statistics & numerical data MeSH
- Middle Aged MeSH
- Humans MeSH
- Mastectomy methods statistics & numerical data MeSH
- Breast Neoplasms epidemiology pathology therapy MeSH
- Disease-Free Survival statistics & numerical data MeSH
- Radiotherapy methods statistics & numerical data MeSH
- Aged MeSH
- Treatment Outcome MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Comparative Study MeSH
- MeSH
- Humans MeSH
- Mastectomy methods statistics & numerical data trends MeSH
- Breast Neoplasms surgery MeSH
- Check Tag
- Humans MeSH